Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake

Page 2 of 16

Page 2 of 16 – SEC Filing

SCHEDULE
13D

CUSIP No.    812578102       Page   2   of   16   Pages
1

NAMES OF REPORTING PERSONS

Baker Bros. Advisors LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)¨

(b)¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

OO

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)  ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7

SOLE VOTING POWER

44,209,554 (1)

8

SHARED VOTING POWER

0

9

SOLE DISPOSITIVE POWER

44,209,554 (1)

10

SHARED DISPOSITIVE POWER

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

44,209,554 (1)

12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

31.4% (1)(2)

14

TYPE OF REPORTING PERSON (See Instructions)

IA, PN

(1) Includes 109,260 shares of the Issuer’s common stock
underlying 109,260 options.

(2) Based
on 140,516,451 shares of common stock
as of July 20, 2016 as reported in the Issuer’s 10-Q filed with the SEC on July
26, 2016.

Page 2 of 16

Follow Seagen Inc. (NASDAQ:SGEN)












Page 2 of 16